Perinatal exposure to perfluorooctane sulfonate affects glucose metabolism in adult offspring

scientific article (publication date: 2014)

Perinatal exposure to perfluorooctane sulfonate affects glucose metabolism in adult offspring is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2014PLoSO...987137W
P356DOI10.1371/JOURNAL.PONE.0087137
P932PMC publication ID3909066
P698PubMed publication ID24498028
P5875ResearchGate publication ID260108868

P2093author name stringChris K C Wong
Hin T Wan
Yin G Zhao
Pik Y Leung
P2860cites workPolyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000Q24680576
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manQ26776977
Selection of the appropriate method for the assessment of insulin resistanceQ27001024
Analyzing real-time PCR data by the comparative C(T) methodQ28131831
Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop reviewQ28258639
The paradox of progress: environmental disruption of metabolism and the diabetes epidemicQ28389669
Perinatal exposure to bisphenol-a and the development of metabolic syndrome in CD-1 mice.Q33874480
Endocrine disruptors: from endocrine to metabolic disruptionQ34024583
Obesity, the Metabolic Syndrome, and Type 2 Diabetes in Developing Countries: Role of Dietary Fats and OilsQ34136612
Endocrine disruptors in the etiology of type 2 diabetes mellitus.Q34176083
Sex is a major determinant of CYP3A4 expression in human liverQ34265530
Perfluoroalkyl acids: a review of monitoring and toxicological findingsQ34630884
How important are gender differences in pharmacokinetics?Q34660699
Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workersQ34680365
Obesity, diabetes mellitus, and liver fibrosisQ34979922
Isomer profiles of perfluorochemicals in matched maternal, cord, and house dust samples: manufacturing sources and transplacental transferQ35579871
Gender-specific induction of cytochrome P450s in nonylphenol-treated FVB/NJ miceQ35970874
Metabolic actions of insulin-like growth factor-I in normal physiology and diabetesQ36029231
Nutrition can modulate the toxicity of environmental pollutants: implications in risk assessment and human health.Q36064775
Focus on prolactin as a metabolic hormone.Q36413921
Ecotoxicological evaluation of perfluorooctanesulfonate (PFOS).Q36469189
Involvement of insulin-like growth factor-I in the control of glucose homeostasisQ36618420
Emerging endocrine disrupters: perfluoroalkylated substancesQ37100285
Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adultsQ37139485
Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistanceQ37269509
Neonatal-maternal factors and perfluoroalkyl substances in cord blood.Q50853255
Developmental exposure to di(2-ethylhexyl) phthalate impairs endocrine pancreas and leads to long-term adverse effects on glucose homeostasis in the rat.Q51372050
Evaluation of placental and lactational pharmacokinetics of PFOA and PFOS in the pregnant, lactating, fetal and neonatal rat using a physiologically based pharmacokinetic model.Q51421719
Sex-dependent regulation of hepatic cytochrome P-450 by DDT.Q52538614
Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate.Q53586587
PFOS-induced hepatic steatosis, the mechanistic actions on β-oxidation and lipid transport.Q54315844
Sex is a major determinant of CYP3A4 expression in human liverQ56453603
Toxicogenomic Study of Triazole Fungicides and Perfluoroalkyl Acids in Rat Livers Predicts Toxicity and Categorizes Chemicals Based on Mechanisms of ToxicityQ57555731
Trans-Placental Transfer of Thirteen Perfluorinated Compounds and Relations with Fetal Thyroid HormonesQ58765976
Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetesQ80178930
Effect of dietary fat on oral bioavailability of tepoxalin in dogsQ81844124
Improved selectivity for the analysis of maternal serum and cord serum for polyfluoroalkyl chemicalsQ82486634
Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhoushan, ChinaQ83829339
Perinatal exposure to bisphenol A at reference dose predisposes offspring to metabolic syndrome in adult rats on a high-fat dietQ84131647
Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeysQ84884523
Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemicQ37853813
Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liverQ38034704
Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications.Q38072021
Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC)Q39233321
Levels of 12 perfluorinated chemicals in pooled australian serum, collected 2002-2003, in relation to age, gender, and regionQ39761709
Structure-activity relationships and human relevance for perfluoroalkyl acid-induced transcriptional activation of peroxisome proliferation in liver cell culturesQ39858220
Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoidQ42801273
Determination of energies and sites of binding of PFOA and PFOS to human serum albumin.Q42844971
Dietary intake estimate for perfluorooctanesulphonic acid (PFOS) and other perfluorocompounds (PFCs) in UK retail foods following determination using standard addition LC-MS/MS.Q43144402
Prenatal and postnatal impact of perfluorooctane sulfonate (PFOS) on rat development: a cross-foster study on chemical burden and thyroid hormone systemQ43238768
Gene expression profiling in the liver and lung of perfluorooctane sulfonate-exposed mouse fetuses: comparison to changes induced by exposure to perfluorooctanoic acidQ43679963
Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, MarylandQ43822053
Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeysQ44035477
Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicalsQ44384066
Comparison on gestation and lactation exposure of perfluorinated compounds for newbornsQ44413711
Risk assessment for human consumption of perfluorinated compound-contaminated freshwater and marine fish from Hong Kong and XiamenQ44761825
Blood plasma concentrations of endocrine disrupting chemicals in Hong Kong populationsQ46183320
Perfluorooctane sulfonate-induced changes in fetal rat liver gene expressionQ46436503
Studies on the toxicological effects of PFOA and PFOS on rats using histological observation and chemical analysisQ46460012
Gene expression profiles in rat liver treated with perfluorooctanoic acid (PFOA).Q46750192
Lipid homeostasis and oxidative stress in the liver of male rats exposed to perfluorododecanoic acidQ46889241
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)e87137
P577publication date2014-01-01
P1433published inPLOS OneQ564954
P1476titlePerinatal exposure to perfluorooctane sulfonate affects glucose metabolism in adult offspring
P478volume9

Reverse relations

cites work (P2860)
Q58566708Dietary Exposure to the Environmental Chemical, PFOS on the Diversity of Gut Microbiota, Associated With the Development of Metabolic Syndrome
Q28383132EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
Q38799058Embryonic exposures to perfluorooctanesulfonic acid (PFOS) disrupt pancreatic organogenesis in the zebrafish, Danio rerio
Q64946920Endocrine-disrupting chemicals and risk of diabetes: an evidence-based review.
Q39400487Exposure to Perfluorinated Alkyl Substances and Health Outcomes in Children: A Systematic Review of the Epidemiologic Literature
Q36710350Metabolic disruption in context: Clinical avenues for synergistic perturbations in energy homeostasis by endocrine disrupting chemicals
Q29248099Metabolism Disrupting Chemicals and Metabolic Disorders
Q64945556Perfluoroalkyl substances, metabolomic profiling, and alterations in glucose homeostasis among overweight and obese Hispanic children: A proof-of-concept analysis.
Q63255349Perfluorobutanesulfonic Acid Disrupts Pancreatic Organogenesis and Regulation of Lipid Metabolism in the Zebrafish, Danio rerio
Q33683116Perfluorooctanesulfonate (PFOS)-induced Sertoli cell injury through a disruption of F-actin and microtubule organization is mediated by Akt1/2
Q50041783Perfluorooctanoic acid impaired glucose homeostasis through affecting adipose AKT pathway
Q51246138Plasma Concentrations of Perfluoroalkyl Substances and Risk of Type 2 Diabetes: A Prospective Investigation among U.S. Women.
Q38692106Polluted Pathways: Mechanisms of Metabolic Disruption by Endocrine Disrupting Chemicals
Q62086877Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food

Search more.